Rivastigmine for Antimuscarinic Delirium

Clinical trial NCT06382649 · RECRUITING

Trial details

NCT number: NCT06382649
Sponsor: Washington University School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anticholinergic Toxicity

Start date: 2026-06-01
Primary completion: 2028-11-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.